Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Swiss Exchange  >  Clariant    CLN   CH0012142631

CLARIANT (CLN)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

Clariant : Introduces Tri-Sorb® Desiccant Tablets for USP Moisture Testing of Blister...

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/05/2017 | 07:10am CEST
  • New source for important testing component
  • Smaller package quantities ideal for testing applications
  • Tablet experts to appear at industry tradeshows

Muttenz, October 5, 2017 - Clariant, a world leader in Specialty Chemicals, with its Healthcare Packaging business unit, is introducing Tri-Sorb molecular sieve desiccant tablets specifically designed for USP moisture permeability testing at several upcoming industry events.

The new tablets have been developed for pharmaceutical and nutraceutical packagers who are conducting moisture-permeation testing of unit-dose blister packaging as prescribed in USP . The Tri-Sorb tablets are designed for placement into blister headspaces, either singly or in multiples, in lieu of the actual drug product, where they are used to test and verify the moisture vapor transmission rate, or MTVR, of blister packaging according to the USP standard.

The tablets are packaged in quantities suitable for laboratory testing applications, with 320-350 tablets, depending on tablet size, in each re-sealable barrier pouch. To ensure product integrity and moisture adsorbtion capacity, Tri-Sorb desiccant tablets are not repackaged by a third party, but packaged directly on-site as part of the manufacturing process.

'Pharmaceutical manufacturers depend heavily on the results of USP testing to ensure that their drug packaging consistently achieves its specified MVTR,' says Audrey Pouliquen, Product Manager, Clariant Healthcare Packaging. 'Clariant has developed this line of desiccant tablets to specifically meet the requirements for this essential test.'

Tri-Sorb tablets are made from 4A molecular sieve and are available in three sizes: 0.125g, 0.25g and 0.37g. Similar Tri-Sorb tablets are also widely used in the packaging of medical devices and rapid diagnostic tests, where they protect functionality, accuracy, and shelf life from being compromised by moisture.

Complete product performance information and samples are available by contacting Clariant at healthpack.clariant.com. Product experts will be available to discuss the newly launched tablets at the following upcoming pharmaceutical and nutraceutical industry events:

  • CPHI Worldwide - Messe Frankfurt, Frankfurt, Germany, October 24-26, Booth 42L20 (www.cphi.com).
  • American Association of Pharmaceutical Scientists (AAPS) - San Diego Convention Center, San Diego, CA USA, November 13-15, Booth 1549, (www.aaps.org/annualmeeting).

Tri-Sorb® IS A TRADEMARK OF CLARIANT REGISTERED IN MANY COUNTRIES.

Clariant AG published this content on 05 October 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 05 October 2017 05:09:03 UTC.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CLARIANT
07:07aCLARIANT : ColorForward® 2019 Inspires Mold-Texture Specialist
PU
07/04CLARIANT : expands EnviCat catalyst portfolio for selective catalytic reduction ..
AQ
07/03CLARIANT CHEMICALS INDIA :
AQ
07/03CLARIANT : MILITARY USAF Awards Contract to Reliant Aluminum Products for Chemic..
AQ
07/03CLARIANT : expands EnviCat catalyst portfolio for selective catalytic reduction ..
AQ
06/26CLARIANT : enhances capabilities at Clinton, Oklahoma facility
PU
06/26CLARIANT : extends EnviCat® catalyst portfolio to offer extruded SCR NOx solutio..
PU
06/23CLARIANT : Stabilizer Jv Breaks Ground for New Plant in China
AQ
06/22CLARIANT : Opens Two New Facilities in China for Additive Production
AQ
06/21CLARIANT : breaks ground on joint venture production site in Cangzhou, China
PU
More news
News from SeekingAlpha
06/08Clariant (CLZNY) Presents At Credit Suisse 2018 Global Chemicals And Agricult.. 
04/25Clariant (CLZNF) Q1 2018 Results - Earnings Call Transcript 
04/25Clariant beats by CHF 3.4M on EBITDA, beats on revenue 
04/25Clariant AG 2018 Q1 - Results - Earnings Call Slides 
02/23Tracking Alex Roepers' Atlantic Investment Management Portfolio - Q4 2017 Upd.. 
Financials ( CHF)
Sales 2018 6 710 M
EBIT 2018 734 M
Net income 2018 429 M
Debt 2018 1 454 M
Yield 2018 2,28%
P/E ratio 2018 18,53
P/E ratio 2019 16,54
EV / Sales 2018 1,39x
EV / Sales 2019 1,30x
Capitalization 7 866 M
Chart CLARIANT
Duration : Period :
Clariant Technical Analysis Chart | CLN | CH0012142631 | 4-Traders
Technical analysis trends CLARIANT
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 18
Average target price 25,8  CHF
Spread / Average Target 9,1%
EPS Revisions
Managers
NameTitle
Hariolf Kottmann Chief Executive Officer & Executive Director
Rudolf Wehrli Chairman
Patrick Jany Chief Financial Officer
Peter Chen Non-Executive Director
Carlo G. Soave Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
CLARIANT-13.32%7 893
ECOLAB6.29%41 305
SIKA AG0.00%21 076
SYMRISE8.82%11 869
INDORAMA VENTURES PCL--.--%9 548
JOHNSON MATTHEY PLC19.64%9 395